Japanese Correspondence
Yamada Science Foundation
YSF TOPOverview of YSFSupport for ScienceYamada Conference : YCYamada Symposium : YSResearch and YC YS ReportsPastsupport

Progress Report of YSF Supported Science Program


Summary of Research Projects (Supports in 2003 Fiscal Year)
returns to the listreturns to the list
Subjects Development of Subtype-Selective Ligands for Glutamate Receptors
Representative researcher Tohoku University Makoto SASAKI
Joint researcher Tohoku University Masato OIKAWA
Kitasato University Ryuichi SAKAI
Dysiherbaine (1) is a marine sponge-derived excitatory amino acid with potent convulsant activity. This novel amino acid activates neuronal non-N-methyl-D-aspartate (non-NMDA) type glutamate receptors (GluR), namely, AMPA and kainic acid (KA) receptors, with considerable preference over KA receptors. Moreover, characterization of DH actions on recombinant GluRs revealed that the selective binding to the GluR5 and GluR6 subunits was of high affinity. Because of these intriguing pharmacological properties to KA receptors, as well as its potent epileptogenic action, DH and its designed analogues are anticipated to serve as useful tools for investigating GluR structure and function in the central nervous system. In order to reveal detailed structure-activity relationship profiles of dysiherbaines, we have developed a concise and efficient synthetic route to dysiherbaine analogue 4. The synthesis features a stereoselective C-glycosidation to set the C6 stereocenter and epoxide opening/ring closure to form tetrahydrofuran ring. We also characterized the pharmacological activity of simplified model compound 3, which lacks the C8 and C9 functional groups of dysiherbaine. Radioligand binding assays and electrophysiological studies revealed compound 3 to be a selective antagonist to GluR5 KA receptor.